Insulin Market Size And Share

  • Report Code : TIPRE00004051
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 186
Buy Now

Insulin Market Size, Top Players, and Forecast by 2028

Buy Now

Insulin Market Report Insulin Market Scope and Analysis Insulin Market Size and Share

Insulin Market: Strategic Insights

Insulin Market

  • CAGR (2022 - 2028)
    10.8%
  • Market Size 2022
    US$ 60.18 Billion
  • Market Size 2028
    US$ 111.21 Billion

Market Dynamics

GROWTH DRIVERS
  • Increase in diabetes prevalence
  • Growth in demand for insulin therapies
FUTURE TRENDS
  • Increasing adoption of insulin pumps and pens
  • Development of insulin biosimilars and new delivery technologies
OPPORTUNITIES
  • Expansion in diabetes management market
  • Growth in insulin pen and pump usage

Key Players

  • Eli Lily and Company
  • Novo NordiskA S
  • Biocon
  • Wockhardt
  • Adocia
  • GlaxoSmitheKline plc
  • Sanofi
  • Pfizer
  • Merck Co Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Long Acting Insulin
  • Rapid Acting Insulins
  • Short acting Insulins and Traditional Human Insulins
  • Concentrated Insulins and Combination Insulins
  • Biosimilar Insulins
  • Glucagon-like peptide-1
  • Pens and Needles